Gobbi G, Cassano T, Radja F, Morgese MG, Cuomo V, Santarelli L, Hen R, Blier P (2007). "Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function". European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology17 (5): 328–38. PMID16950604. doi:10.1016/j.euroneuro.2006.07.004.
Kovács KA, Steinmann M, Magistretti PJ, Halfon O, Cardinaux JR (2006). "C/EBPbeta couples dopamine signalling to substance P precursor gene expression in striatal neurones". Journal of Neurochemistry98 (5): 1390–9. PMID16771829. doi:10.1111/j.1471-4159.2006.03957.x.
Rameshwar P (1997). "Substance P: a regulatory neuropeptide for hematopoiesis and immune functions". Clinical Immunology and Immunopathology85 (2): 129–33. PMID9344694. doi:10.1006/clin.1997.4446.
Hesketh PJ (2001). "Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting". Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer9 (5): 350–4. PMID11497388. doi:10.1007/s005200000199.
Hornby PJ (2001). "Central neurocircuitry associated with emesis". The American Journal of Medicine. 111. Suppl 8A (8): 106S–112S. PMID11749934. doi:10.1016/S0002-9343(01)00849-X.
Donkin JJ, Nimmo AJ, Cernak I, Blumbergs PC, Vink R (2009). "Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury". J Cereb Blood Flow Metab.29 (8): 1388–98. PMID19436311. doi:10.1038/jcbfm.2009.63.
Stark D, van Hal S, Marriott D, Ellis J, Harkness J (2007). "Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis". Int. J. Parasitol.37 (1): 11–20. PMID17070814. doi:10.1016/j.ijpara.2006.09.009.
Park TJ, Comer C, Carol A, Lu Y, Hong HS, Rice FL (2003). "Somatosensory organization and behavior in naked mole-rats: II. Peripheral structures, innervation, and selective lack of neuropeptides associated with thermoregulation and pain". J Comp Neurol465 (1): 104–20. PMID12926019. doi:10.1002/cne.10824.
Gobbi G, Cassano T, Radja F, Morgese MG, Cuomo V, Santarelli L, Hen R, Blier P (2007). "Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function". European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology17 (5): 328–38. PMID16950604. doi:10.1016/j.euroneuro.2006.07.004.
Kovács KA, Steinmann M, Magistretti PJ, Halfon O, Cardinaux JR (2006). "C/EBPbeta couples dopamine signalling to substance P precursor gene expression in striatal neurones". Journal of Neurochemistry98 (5): 1390–9. PMID16771829. doi:10.1111/j.1471-4159.2006.03957.x.
Rameshwar P (1997). "Substance P: a regulatory neuropeptide for hematopoiesis and immune functions". Clinical Immunology and Immunopathology85 (2): 129–33. PMID9344694. doi:10.1006/clin.1997.4446.
Hesketh PJ (2001). "Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting". Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer9 (5): 350–4. PMID11497388. doi:10.1007/s005200000199.
Zubrzycka M, Janecka A (2000). "Substance P: transmitter of nociception (Minireview)". Endocrine regulations34 (4): 195–201. PMID11137976.
Hornby PJ (2001). "Central neurocircuitry associated with emesis". The American Journal of Medicine. 111. Suppl 8A (8): 106S–112S. PMID11749934. doi:10.1016/S0002-9343(01)00849-X.
Donkin JJ, Nimmo AJ, Cernak I, Blumbergs PC, Vink R (2009). "Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury". J Cereb Blood Flow Metab.29 (8): 1388–98. PMID19436311. doi:10.1038/jcbfm.2009.63.
Brown SM, Lamberts DW, Reid TW, Nishida T, Murphy CJ (1997). "Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1". Archives of Ophthalmology115 (7): 926–7. PMID9230840.
Tsui H, Razavi R, Chan Y, Yantha J, Dosch HM (2007). "'Sensing' autoimmunity in type 1 diabetes". Trends in Molecular Medicine13 (10): 405–13. PMID17900987. doi:10.1016/j.molmed.2007.07.006.
Bossaller C, Reither K, Hehlert-Friedrich C, Auch-Schwelk W, Graf K, Gräfe M, Fleck E (1992). "In vivo measurement of endothelium-dependent vasodilation with substance P in man". Herz17 (5): 284–90. PMID1282120.
Steinitz H (1979). "[Chronic recurrent intestinal amebiasis in Israel (author's transl)]". Leber, Magen, Darm(en German)9 (4): 175–9. PMID491812.
Stark D, van Hal S, Marriott D, Ellis J, Harkness J (2007). "Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis". Int. J. Parasitol.37 (1): 11–20. PMID17070814. doi:10.1016/j.ijpara.2006.09.009.
McGowan K, Guerina V, Wicks J, Donowitz M (1985). "Secretory hormones of Entamoeba histolytica". Ciba Found. Symp.112: 139–54. PMID2861068.
Park TJ, Comer C, Carol A, Lu Y, Hong HS, Rice FL (2003). "Somatosensory organization and behavior in naked mole-rats: II. Peripheral structures, innervation, and selective lack of neuropeptides associated with thermoregulation and pain". J Comp Neurol465 (1): 104–20. PMID12926019. doi:10.1002/cne.10824.